- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03628248
Effect of Endovascular Inferior Mesenteric Artery Embolization on Colonic Perfusion Prior to Rectal Surgery for Rectal Tumor or Sigmoid Colon Surgery (AMIREMBOL)
August 3, 2021 updated by: Centre Hospitalier Universitaire de Nīmes
Effect of Endovascular Inferior Mesenteric Artery Embolization on Colonic Perfusion Prior to Rectal Surgery for Rectal Tumor or Sigmoid Colon Surgery - A Single-center Feasibility Pilot Study.
The investigators hypothesize that a primary embolization, 3-4 weeks before surgery, would allow development of vascular collaterality, in particular for the marginal artery which will ensure a better colonic perfusion.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nimes, France, 30029
- CHU Nîmes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The patient must have given their free and informed consent and signed the consent form
- The patient must be a member or beneficiary of a health insurance plan
- The patient is at least 18 years old and less than 80 years old
- Patient has rectal cancer or sigmoid colon cancer requiring surgical treatment
Exclusion Criteria:
- The subject is participating in another study, or is in a period of exclusion determined by a previous study
- The subject refuses to sign the consent
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- Patient has a history of abdominal surgery
- Patient suffers from a hemostasis disorder (hemophilia, von Willebrand disease, thrombocytopenia) and is on anticoagulant therapy.
- Patient whose general condition appears too precarious or is taking corticosteroids or immunosuppressants leading to an unacceptable surgical risk.
- Renal insufficiency with clearance <45ml / min
- Known allergy to contrast media
- Patient who had treatment of the abdominal aorta or its branches Reported pregnancy (the existence of effective contraception will be verified for women of childbearing age).
- Anatomical variant at risk or absence of marginal artery highlighted at the time of arteriography.
- Abnormality of the superior mesenteric artery
- Historic occlusion of the inferior mesenteric artery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: embolization
|
proximal occlusion of the inferior mesenteric artery, before its divisional branches, by coils or plug 3-4 weeks prior to surgery.
Endovascular ligation of Inferior mesenteric artery
|
Other: No embolization
|
Endovascular ligation of Inferior mesenteric artery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxygen saturation of the colon after inferior mesenteric artery ligation between groups
Time Frame: Prior to start of surgery
|
Digital oxymeter (%)
|
Prior to start of surgery
|
Arterial pressure after inferior mesenteric artery ligation between groups
Time Frame: Prior to start of surgery
|
Average (mmHg)
|
Prior to start of surgery
|
Colonic perfusion in the marginal artery after inferior mesenteric artery ligation between groups
Time Frame: Prior to start of surgery
|
Rectal resistance index measured by Doppler
|
Prior to start of surgery
|
Oxygen saturation of the colon after inferior mesenteric artery ligation between groups
Time Frame: 60 seconds after surgery
|
Digital oxymeter (%)
|
60 seconds after surgery
|
Oxygen saturation of the colon after inferior mesenteric artery ligation between groups
Time Frame: 5 minutes after surgery
|
Digital oxymeter (%)
|
5 minutes after surgery
|
Arterial pressure in the marginal artery after inferior mesenteric artery ligation between groups
Time Frame: 60 seconds after surgery
|
Average (mmHg)
|
60 seconds after surgery
|
Arterial pressure in the marginal artery after inferior mesenteric artery ligation between groups
Time Frame: 5 minutes after surgery
|
Average (mmHg)
|
5 minutes after surgery
|
Colonic perfusion in the marginal artery after inferior mesenteric artery ligation between groups
Time Frame: 60 seconds after surgery
|
Rectal resistance index measured by Doppler
|
60 seconds after surgery
|
Colonic perfusion in the marginal artery after inferior mesenteric artery ligation between groups
Time Frame: 5 minutes after surgery
|
Rectal resistance index measured by Doppler
|
5 minutes after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of post-embolization complications
Time Frame: Day 5 post-emoblization
|
Yes/No
|
Day 5 post-emoblization
|
Presence of post-surgery complications
Time Frame: Hospital discharge (Day 7 after surgery)
|
Yes/No
|
Hospital discharge (Day 7 after surgery)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Martin Bertrand, MD, CHU Nîmes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 10, 2020
Primary Completion (Actual)
June 24, 2021
Study Completion (Actual)
June 24, 2021
Study Registration Dates
First Submitted
August 9, 2018
First Submitted That Met QC Criteria
August 9, 2018
First Posted (Actual)
August 14, 2018
Study Record Updates
Last Update Posted (Actual)
August 4, 2021
Last Update Submitted That Met QC Criteria
August 3, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIMAO/2017-02/JF-02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer, Rectum
-
Washington University School of MedicineCompletedRectal Cancer | Cancer of Rectum | Cancer of the Rectum | Neoplasm, Rectum | Rectum Cancer | Rectum Neoplasms | Adenocarcinoma of the RectumUnited States
-
Wuhan Union Hospital, ChinaRecruitingRectal Cancer | Cancer of Rectum | Cancer of the Rectum | Rectum Cancer | Rectum Neoplasms | Neoplasms, Rectal | Rectal TumorsChina
-
University of UtahNot yet recruitingMetastatic Colon Cancer | Metastatic Rectum CancerUnited States
-
Vejle HospitalAarhus University HospitalTerminated
-
San Carlo di Nancy HospitalRecruitingColorectal Cancer | Anastomotic Leak | Colon Cancer | Colon Neoplasm | Rectum Cancer | Rectum Neoplasm | Anastomotic Leak Rectum | Anastomotic Leak Large IntestineItaly
-
AC Camargo Cancer CenterUnknownColon Cancer Stage IIb | Rectum Cancer, Adenocarcinoma | Colon Cancer Stage IIIa | Colon Cancer Stage IIIc | Colon Cancer Stage IIIbBrazil
-
Mater Misericordiae University HospitalPenn State University; Krankenhaus der Barmherzigen Bruder Graz; Institut de... and other collaboratorsNot yet recruitingRectal Cancer | Rectum Neoplasm | Rectum PolypIreland
-
Peking University Third HospitalCompleted
-
Federation Francophone de Cancerologie DigestiveCompletedAdenocarcinoma of RectumFrance
-
Centre Hospitalier Universitaire, AmiensCompletedHernia | Diverticulitis | Colon Cancer | Rectal Bleeding | Upper Rectum CancerFrance
Clinical Trials on embolization of the inferior mesenteric artery
-
University Hospital, GrenobleUniversity Hospital, Clermont-Ferrand; Groupe Hospitalier Mutualiste de GrenobleRecruitingEmbolism MesentericFrance
-
Corporacion Parc TauliSheila Serra-Pla; Laura Mora-Lopez; Paula Planelles-Soler; Naim Hannaoui; Arturo... and other collaboratorsUnknown
-
University of Roma La SapienzaCompletedDefecatory Disorders After Left Colonic or Rectal ResectionItaly
-
University of Roma La SapienzaCompleted
-
Institut d'Investigació Biomèdica de Girona Dr....CompletedColorectal Cancer | Rectal TumorsSpain
-
Sohag UniversityRecruiting
-
Group of Research in Minimally Invasive TechniquesUniversidad de Zaragoza; Hospital Clínico Universitario Lozano BlesaWithdrawnBenign Prostatic HyperplasiaSpain
-
Ospedale Policlinico San MartinoNot yet recruitingEndovascular vs Conservative Treatment in Patients With Chronic Subdural Hematomas and Mild SymptomsSubdural Hematoma, Chronic
-
University of ManitobaRecruitingSubdural HematomaCanada
-
Zhejiang UniversityRecruitingSurgical Blood Loss | Tumor of PancreasChina